Automated processing of Meryman-frozen red blood cells: A novel protocol for deglycerolization.

IF 2 3区 医学 Q2 HEMATOLOGY Transfusion Pub Date : 2025-04-01 Epub Date: 2025-03-14 DOI:10.1111/trf.18211
Audrey Laforce-Lavoie, Jessica Constanzo-Yanez, Marie-Claire Chevrier, Marc Cloutier
{"title":"Automated processing of Meryman-frozen red blood cells: A novel protocol for deglycerolization.","authors":"Audrey Laforce-Lavoie, Jessica Constanzo-Yanez, Marie-Claire Chevrier, Marc Cloutier","doi":"10.1111/trf.18211","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Many blood services maintain large inventories of red blood cell (RBC) units cryopreserved in glycerol using the Meryman method. With the discontinuation of the COBE® 2991 cell processor, an alternative thawing method is needed. We aimed to develop a deglycerolization protocol for Meryman-frozen units using the ACP® 215 cell washer.</p><p><strong>Methods: </strong>In the optimization phase, Meryman-frozen RBC units stored for 10 years were thawed, paired, and divided into two groups: one with a centrifugation step to remove glycerol before deglycerolization (\"volume reduction\") and one without. Biochemical and hematological parameters assessed included hemolysis, hematocrit, hemoglobin, ATP, pH, and osmolality. The protocol was then validated.</p><p><strong>Results: </strong>Hemolysis rates were lower with than without volume reduction (0.4% vs. 0.6%). Centrifuged RBCs also showed higher recovery (72% vs. 63%), increased hematocrit (0.51 L/L vs. 0.40 L/L), and improved pH stability (6.17 vs. 6.11). In the validation phase, six RBC units deglycerolized using the volume reduction step met Canadian Standards Association requirements for hematocrit, hemoglobin, hemolysis, and sterility.</p><p><strong>Discussion: </strong>We optimized and validated a new protocol leveraging the ACP® 215 cell washer to deglycerolize Meryman-frozen RBCs. This method yielded low hemolysis, acceptable pH, and satisfactory recovery, especially with prior glycerol removal by centrifugation. The protocol has been successfully implemented, and Meryman-frozen RBC units have since been reliably thawed, meeting regulatory standards and supporting hospital needs.</p>","PeriodicalId":23266,"journal":{"name":"Transfusion","volume":" ","pages":"732-739"},"PeriodicalIF":2.0000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transfusion","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/trf.18211","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/14 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Many blood services maintain large inventories of red blood cell (RBC) units cryopreserved in glycerol using the Meryman method. With the discontinuation of the COBE® 2991 cell processor, an alternative thawing method is needed. We aimed to develop a deglycerolization protocol for Meryman-frozen units using the ACP® 215 cell washer.

Methods: In the optimization phase, Meryman-frozen RBC units stored for 10 years were thawed, paired, and divided into two groups: one with a centrifugation step to remove glycerol before deglycerolization ("volume reduction") and one without. Biochemical and hematological parameters assessed included hemolysis, hematocrit, hemoglobin, ATP, pH, and osmolality. The protocol was then validated.

Results: Hemolysis rates were lower with than without volume reduction (0.4% vs. 0.6%). Centrifuged RBCs also showed higher recovery (72% vs. 63%), increased hematocrit (0.51 L/L vs. 0.40 L/L), and improved pH stability (6.17 vs. 6.11). In the validation phase, six RBC units deglycerolized using the volume reduction step met Canadian Standards Association requirements for hematocrit, hemoglobin, hemolysis, and sterility.

Discussion: We optimized and validated a new protocol leveraging the ACP® 215 cell washer to deglycerolize Meryman-frozen RBCs. This method yielded low hemolysis, acceptable pH, and satisfactory recovery, especially with prior glycerol removal by centrifugation. The protocol has been successfully implemented, and Meryman-frozen RBC units have since been reliably thawed, meeting regulatory standards and supporting hospital needs.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
meryman冷冻红细胞的自动处理:一种脱甘油的新方案。
背景:许多血液服务机构使用Meryman方法在甘油中保存大量红细胞(RBC)单位。随着COBE®2991细胞处理机的停产,需要一种替代的解冻方法。我们的目标是使用ACP®215细胞清洗机开发meryman冷冻单位的脱甘油方案。方法:在优化阶段,将保存10年的Meryman-frozen RBC单元解冻、配对并分为两组:一组在脱甘油前进行离心步骤去除甘油(“体积缩小”),另一组不进行离心步骤。评估的生化和血液学参数包括溶血、红细胞压积、血红蛋白、ATP、pH和渗透压。然后验证该协议。结果:减容组溶血率低于未减容组(0.4% vs. 0.6%)。离心后的红细胞也显示出更高的回收率(72% vs. 63%),红细胞压积增加(0.51 L/L vs. 0.40 L/L), pH稳定性提高(6.17 vs. 6.11)。在验证阶段,使用体积缩小步骤脱甘油的6个RBC单位符合加拿大标准协会对红细胞压积、血红蛋白、溶血和无菌的要求。讨论:我们优化并验证了一种利用ACP®215细胞洗涤器对meryman冷冻红细胞进行脱甘油的新方案。这种方法产生低溶血,可接受的pH值,和令人满意的回收率,特别是事先通过离心去除甘油。该方案已成功实施,meryman冷冻RBC单位已可靠解冻,符合监管标准并支持医院需求。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Transfusion
Transfusion 医学-血液学
CiteScore
4.70
自引率
20.70%
发文量
426
审稿时长
1 months
期刊介绍: TRANSFUSION is the foremost publication in the world for new information regarding transfusion medicine. Written by and for members of AABB and other health-care workers, TRANSFUSION reports on the latest technical advances, discusses opposing viewpoints regarding controversial issues, and presents key conference proceedings. In addition to blood banking and transfusion medicine topics, TRANSFUSION presents submissions concerning patient blood management, tissue transplantation and hematopoietic, cellular, and gene therapies.
期刊最新文献
Low titer group O whole blood inventory conservation: The effect of implementing group A whole blood at a simulated civilian trauma center. Glycemic control and blood product quality of Canadian blood donors with diabetes. Novel RHD*49C allele identified in a prenatal patient. Successful re-infusion of hepatitis E contaminated stem cells during autologous stem cell transplantation with ribavirin prophylaxis. Novel RHCE*cE(341A) allele.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1